Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
INKT MiNK Therapeutics Inc
- Stocks
- Healthcare
- NASDAQ: INKT
Price (delayed)
$6.91
Market cap
$27.54M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.56
Enterprise value
$29.42M
Highlights
INKT's EPS has surged by 57% year-on-year and by 10% since the previous quarter
MiNK Therapeutics's net income has surged by 53% YoY and by 10% QoQ
MiNK Therapeutics's quick ratio has plunged by 59% from the previous quarter and by 48% YoY
The debt has grown by 22% YoY and by 3.9% from the previous quarter
Key stats
What are the main financial stats of INKT
Market
Valuations
Earnings
Shares outstanding
3.99M
Market cap
$27.54M
Enterprise value
$29.42M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$10.16M
Net income
-$9.74M
EBIT
-$9.74M
EBITDA
-$9.53M
Free cash flow
-$8.35M
Per share
Balance sheet
Liquidity
EPS
-$2.56
EPS diluted
-$2.56
Free cash flow per share
-$2.11
Book value per share
-$5.49
Revenue per share
$0
TBVPS
$1.08
Total assets
$4.27M
Total liabilities
$26.06M
Debt
$5.12M
Equity
-$21.79M
Working capital
-$8.54M
Debt to equity
-0.23
Current ratio
0.3
Quick ratio
0.27
Net debt/EBITDA
-0.2
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-140.7%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INKT stock price
How has the MiNK Therapeutics stock price performed over time
Intraday
-3.63%
1 week
-7.25%
1 month
-3.09%
1 year
-23.31%
YTD
-0.86%
QTD
-6.46%
Financial performance
How have MiNK Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$10.16M
Net income
-$9.74M
Gross margin
N/A
Net margin
N/A
MiNK Therapeutics's net income has surged by 53% YoY and by 10% QoQ
INKT's operating income has soared by 51% YoY and by 10% QoQ
Price vs fundamentals
How does INKT's price correlate with its fundamentals
Growth
What is MiNK Therapeutics's growth rate over time
Valuation
What is MiNK Therapeutics stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
INKT's EPS has surged by 57% year-on-year and by 10% since the previous quarter
MiNK Therapeutics's equity has decreased by 11% from the previous quarter and by 7% YoY
Efficiency
How efficient is MiNK Therapeutics business performance
MiNK Therapeutics's ROA has increased by 47% YoY
Dividends
What is INKT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INKT.
Financial health
How did MiNK Therapeutics financials performed over time
The total assets is 84% lower than the total liabilities
MiNK Therapeutics's quick ratio has plunged by 59% from the previous quarter and by 48% YoY
INKT's current ratio has dropped by 58% since the previous quarter and by 44% year-on-year
The debt is 123% more than the equity
The debt has grown by 22% YoY and by 3.9% from the previous quarter
MiNK Therapeutics's equity has decreased by 11% from the previous quarter and by 7% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.